Skip to main content

MW Holladay

First name:
MW
Last name:
Holladay
Decker, M. W., Bannon, A. W., Curzon, P., Gunther, K. L., Brioni, J. D., Holladay, M. W., et al. (1997). ABT-089 2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride : II. A novel cholinergic channel modulator with effects on cognitive performance in rats and monkeys. The Journal Of Pharmacology And Experimental Therapeutics, 283(1), 247-58. Retrieved de https://jpet.aspetjournals.org/cgi/pmidlookup?view=long&pmid=9336330
Briggs, C. A., Anderson, D. J., Brioni, J. D., Buccafusco, J. J., Buckley, M. J., Campbell, J. E., et al. (1969). Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo. Pharmacology, Biochemistry, And Behavior, 57(1-2), 231-41. https://doi.org/10.1016/s0091-3057(96)00354-1 (Original work published 1969)
Lin, N. H., Gunn, D. E., Ryther, K. B., Garvey, D. S., Donnelly-Roberts, D. L., Decker, M. W., et al. (1997). Structure-activity studies on 2-methyl-3-(2(S)-pyrrolidinylmethoxy) pyridine (ABT-089): an orally bioavailable 3-pyridyl ether nicotinic acetylcholine receptor ligand with cognition-enhancing properties. Journal Of Medicinal Chemistry, 40(3), 385-90. https://doi.org/10.1021/jm960233u (Original work published 1997)